Cargando…

Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy

BACKGROUND: Microvascular dysfunction might be a major determinant of clinical deterioration and outcome in patients with hypertrophic cardiomyopathy (HCM). However, long‐term prognostic value of transthoracic Doppler echocardiography (TDE) coronary flow velocity reserve (CFVR) on clinical outcome i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesic, Milorad, Beleslin, Branko, Giga, Vojislav, Jovanovic, Ivana, Marinkovic, Jelena, Trifunovic, Danijela, Petrovic, Olga, Dobric, Milan, Aleksandric, Srdjan, Juricic, Stefan, Boskovic, Nikola, Tomasevic, Miloje, Ristic, Arsen, Orlic, Dejan, Stojkovic, Sinisa, Vukcevic, Vladan, Stankovic, Goran, Ostojic, Miodrag, Djordjevic Dikic, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751885/
https://www.ncbi.nlm.nih.gov/pubmed/34634920
http://dx.doi.org/10.1161/JAHA.120.021936
_version_ 1784631772958425088
author Tesic, Milorad
Beleslin, Branko
Giga, Vojislav
Jovanovic, Ivana
Marinkovic, Jelena
Trifunovic, Danijela
Petrovic, Olga
Dobric, Milan
Aleksandric, Srdjan
Juricic, Stefan
Boskovic, Nikola
Tomasevic, Miloje
Ristic, Arsen
Orlic, Dejan
Stojkovic, Sinisa
Vukcevic, Vladan
Stankovic, Goran
Ostojic, Miodrag
Djordjevic Dikic, Ana
author_facet Tesic, Milorad
Beleslin, Branko
Giga, Vojislav
Jovanovic, Ivana
Marinkovic, Jelena
Trifunovic, Danijela
Petrovic, Olga
Dobric, Milan
Aleksandric, Srdjan
Juricic, Stefan
Boskovic, Nikola
Tomasevic, Miloje
Ristic, Arsen
Orlic, Dejan
Stojkovic, Sinisa
Vukcevic, Vladan
Stankovic, Goran
Ostojic, Miodrag
Djordjevic Dikic, Ana
author_sort Tesic, Milorad
collection PubMed
description BACKGROUND: Microvascular dysfunction might be a major determinant of clinical deterioration and outcome in patients with hypertrophic cardiomyopathy (HCM). However, long‐term prognostic value of transthoracic Doppler echocardiography (TDE) coronary flow velocity reserve (CFVR) on clinical outcome is uncertain in HCM patients. Therefore, the aim of our study was to assess long‐term prognostic value of CFVR on clinical outcome in HCM population. METHODS AND RESULTS: We prospectively included 150 HCM patients (82 women; mean age 48±15 years). Patients’ clinical characteristics, echocardiographic and CFVR findings (both for left anterior descending [LAD] and posterior descending artery [PD]), were assessed in all patients. The primary outcome was a composite of: HCM related death, heart failure requiring hospitalization, sustained ventricular tachycardia and ischemic stroke. Patients were stratified into 2 subgroups depending on CFVR LAD value: Group 1 (CFVR LAD>2, [n=87]) and Group 2 (CFVR LAD≤2, [n=63]). During a median follow‐up of 88 months, 41/150 (27.3%) patients had adverse cardiac events. In Group 1, there were 8/87 (9.2%), whereas in Group 2 there were 33/63 (52.4%, P<0.001 vs. Group 1) adverse cardiac events. By Kaplan‐Meier analysis, patients with preserved CFVR LAD had significantly higher cumulative event‐free survival rate compared to patients with impaired CFVR LAD (96.4% and 90.9% versus 66.9% and 40.0%, at 5 and 8 years, respectively: log‐rank 37.2, P<0.001). Multivariable analysis identified only CFVR LAD≤2 as an independent predictor for adverse cardiac outcome (HR 6.54; 95% CI 2.83–16.30, P<0.001), while CFVR PD was not significantly associated with outcome. CONCLUSIONS: In patients with HCM, impaired CFVR LAD (≤2) is a strong, independent predictor of adverse cardiac outcome. When the aim of testing is HCM risk stratification and CFVR LAD data are available, the evaluation of CFVR PD is redundant.
format Online
Article
Text
id pubmed-8751885
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87518852022-01-14 Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy Tesic, Milorad Beleslin, Branko Giga, Vojislav Jovanovic, Ivana Marinkovic, Jelena Trifunovic, Danijela Petrovic, Olga Dobric, Milan Aleksandric, Srdjan Juricic, Stefan Boskovic, Nikola Tomasevic, Miloje Ristic, Arsen Orlic, Dejan Stojkovic, Sinisa Vukcevic, Vladan Stankovic, Goran Ostojic, Miodrag Djordjevic Dikic, Ana J Am Heart Assoc Original Research BACKGROUND: Microvascular dysfunction might be a major determinant of clinical deterioration and outcome in patients with hypertrophic cardiomyopathy (HCM). However, long‐term prognostic value of transthoracic Doppler echocardiography (TDE) coronary flow velocity reserve (CFVR) on clinical outcome is uncertain in HCM patients. Therefore, the aim of our study was to assess long‐term prognostic value of CFVR on clinical outcome in HCM population. METHODS AND RESULTS: We prospectively included 150 HCM patients (82 women; mean age 48±15 years). Patients’ clinical characteristics, echocardiographic and CFVR findings (both for left anterior descending [LAD] and posterior descending artery [PD]), were assessed in all patients. The primary outcome was a composite of: HCM related death, heart failure requiring hospitalization, sustained ventricular tachycardia and ischemic stroke. Patients were stratified into 2 subgroups depending on CFVR LAD value: Group 1 (CFVR LAD>2, [n=87]) and Group 2 (CFVR LAD≤2, [n=63]). During a median follow‐up of 88 months, 41/150 (27.3%) patients had adverse cardiac events. In Group 1, there were 8/87 (9.2%), whereas in Group 2 there were 33/63 (52.4%, P<0.001 vs. Group 1) adverse cardiac events. By Kaplan‐Meier analysis, patients with preserved CFVR LAD had significantly higher cumulative event‐free survival rate compared to patients with impaired CFVR LAD (96.4% and 90.9% versus 66.9% and 40.0%, at 5 and 8 years, respectively: log‐rank 37.2, P<0.001). Multivariable analysis identified only CFVR LAD≤2 as an independent predictor for adverse cardiac outcome (HR 6.54; 95% CI 2.83–16.30, P<0.001), while CFVR PD was not significantly associated with outcome. CONCLUSIONS: In patients with HCM, impaired CFVR LAD (≤2) is a strong, independent predictor of adverse cardiac outcome. When the aim of testing is HCM risk stratification and CFVR LAD data are available, the evaluation of CFVR PD is redundant. John Wiley and Sons Inc. 2021-10-12 /pmc/articles/PMC8751885/ /pubmed/34634920 http://dx.doi.org/10.1161/JAHA.120.021936 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Tesic, Milorad
Beleslin, Branko
Giga, Vojislav
Jovanovic, Ivana
Marinkovic, Jelena
Trifunovic, Danijela
Petrovic, Olga
Dobric, Milan
Aleksandric, Srdjan
Juricic, Stefan
Boskovic, Nikola
Tomasevic, Miloje
Ristic, Arsen
Orlic, Dejan
Stojkovic, Sinisa
Vukcevic, Vladan
Stankovic, Goran
Ostojic, Miodrag
Djordjevic Dikic, Ana
Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy
title Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy
title_full Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy
title_fullStr Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy
title_full_unstemmed Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy
title_short Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients With Asymmetric Hypertrophic Cardiomyopathy
title_sort prognostic value of transthoracic doppler echocardiography coronary flow velocity reserve in patients with asymmetric hypertrophic cardiomyopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751885/
https://www.ncbi.nlm.nih.gov/pubmed/34634920
http://dx.doi.org/10.1161/JAHA.120.021936
work_keys_str_mv AT tesicmilorad prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT beleslinbranko prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT gigavojislav prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT jovanovicivana prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT marinkovicjelena prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT trifunovicdanijela prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT petrovicolga prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT dobricmilan prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT aleksandricsrdjan prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT juricicstefan prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT boskovicnikola prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT tomasevicmiloje prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT risticarsen prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT orlicdejan prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT stojkovicsinisa prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT vukcevicvladan prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT stankovicgoran prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT ostojicmiodrag prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy
AT djordjevicdikicana prognosticvalueoftransthoracicdopplerechocardiographycoronaryflowvelocityreserveinpatientswithasymmetrichypertrophiccardiomyopathy